As the company told the “Interfax-Ukraine” news agency, the new service is designed to ensure continuous medical support for patients and a timely response to changes in their condition outside the hospital.
Home care services include the development of an individualized medical monitoring plan, visits by a nurse or paramedic, in-home doctor consultations, diagnostic procedures, monitoring of the patient’s condition, and, if necessary, the involvement of specialized physicians.
In addition, home care services include the option of emergency hospitalization in the event of a deterioration in the patient’s condition.
“The home care service is designed for patients who require medical assistance outside the clinic, particularly those with limited mobility, a need for regular monitoring, or undergoing rehabilitation. This format allows for a comprehensive approach to treatment without hospitalization, providing patients with high-quality medical care in the comfort of their own homes,” Adonis noted.
Adonis is a multidisciplinary medical center for adults and children, founded in 1997. The medical group includes seven modern clinics in Kyiv and the surrounding region, over 80 medical specialties, its own laboratories, surgical centers, inpatient facilities, and departments staffed by specialized professionals.
The ADONIS Medical Group’s private higher education institution (PHEI) has begun recruiting for its residency program. As Lilia Ponamaryova, ADONIS’s Vice Rector for Strategic Development, told Interfax-Ukraine, the residency program is conducted at ADONIS’s modern medical centers, which are equipped with state-of-the-art equipment.
As part of the new recruitment drive, training programs are now available in the following specialties: surgery, neurology, otorhinolaryngology, dermatology and venereology, orthopedics and traumatology, general practice—family medicine, obstetrics, and gynecology.
Interns will work under the supervision of experienced physicians who serve as mentors and impart practical skills and clinical experience.
“We eagerly await new interns who are eager to develop, learn, and work in modern medicine. ADONIS creates all the conditions for professional growth and the start of a successful medical career,” said Ponamaryova.
She noted that the institute already has a successful track record of training interns, and a systematic training model has been developed at the university that combines theory, clinical reasoning, and real-world practice.
ADONIS emphasizes that the residency program is focused on training doctors who work according to the principles of evidence-based medicine, confidently make clinical decisions, and are ready to work with patients from the very first years of their professional careers.
“Our goal is not simply to produce a certified specialist, but a doctor who thinks critically, analyzes, and takes responsibility for clinical decisions. That is why interns are fully engaged in practical work and learn directly in a clinical setting. A high-quality internship is a key stage in a doctor’s development, and we continue to refine our training programs in line with modern medical standards and the needs of the healthcare system,” said Ponamaryova.
The private higher education institution “Institute of General Practice – Family Medicine” was established in 2007 by the ADONIS medical group to train specialists who will receive a state-recognized diploma in the field of specialized and general medical practice. The institution holds a valid license for medical practice.
Founded in 1997, Adonis is a multidisciplinary medical center for adults and children. The medical group includes seven modern clinics in Kyiv and the region, over 80 medical specialties, its own laboratories, surgical centers, inpatient facilities, and departments staffed by specialized professionals.
Adonis Medical Network has begun cooperation with the National Health Service of Ukraine (NHSU) and is signing declarations to provide primary medical care under the Medical Guarantees Program (MGP).
According to Interfax-Ukraine, as part of the cooperation with the NSHU, patients who have signed a declaration will receive a full range of services under the MGP, including consultations with a family doctor, therapist, or pediatrician, dynamic monitoring of chronic diseases, issuance of sick leave certificates, medical certificates, electronic referrals to narrow-profile specialists, and electronic prescriptions under the Affordable Medicines Program, as well as basic laboratory and instrumental examinations.
According to the National Health Service of Ukraine, 479 private medical institutions and 953 individual entrepreneurs have been contracted for primary medical care under the PMG for 2026.
Founded in 1997, Adonis is a multidisciplinary medical center for adults and children. The medical group includes seven modern clinics in Kyiv and the region, more than 80 medical specialties, its own laboratories, operating centers, inpatient facilities, and departments of specialized specialists.
Adonis Multidisciplinary Medical Center has launched the Metabolic Reset program for weight control and obesity treatment.
According to the center’s press release, the new standard of obesity treatment, Metabolic Reset | GLP-1 clinic, involves a comprehensive medical approach that begins with identifying the causes of weight gain, more than 15 laboratory tests, and seven instrumental studies to assess hormonal balance, metabolic status, insulin resistance, body composition, and internal organ function.
“Based on the results of the study, a personalized treatment strategy is developed: drug therapy, correction of eating habits, and elimination of metabolic disorders,” the clinic notes.
The weight control program at Adonis is led by endocrinologist and therapist Kateryna Komisarenko, who has more than 10 years of experience. She specializes in the treatment of metabolic disorders, insulin resistance, and hormone-related weight gain.
According to a study by STEPS and the Ukrainian Ministry of Health, 59% of the country’s adult population is overweight, and about 25% is obese. This means that virtually one in four Ukrainians is obese.
Founded in 1997, Adonis is a multidisciplinary medical center for adults and children. The medical group includes seven modern clinics in Kyiv and the surrounding region, more than 80 medical specialties, its own laboratories, operating centers, inpatient facilities, and departments of specialized specialists.
The draft law “On the Use of Assisted Reproductive Technologies” (No. 13638) could radically change the provision of medical services in the field of reproductive technologies and lead to Ukraine losing its status as the “reproductive hub of Europe.” It requires significant revision with the involvement of the professional expert community, according to experts surveyed by Interfax-Ukraine.
“According to various estimates, up to 40-60% of patients in large reproductive medicine clinics are foreigners (especially from the EU, the UK, the US, Canada, Israel, and China). If the law does not provide for transparent mechanisms for foreign patients, such as official medical visas or agreements between countries, Ukraine may lose its status as the “reproductive hub of Europe,” said Dmytro Biletsky, head of the assisted reproductive technology department at the Adonis Medical Gynecological Center (MGK) Adonis Medical Gynecological Center (MGK).
According to him, Ukraine is currently among the top 10 global destinations for reproductive technologies, thanks in particular to “affordable prices: an IVF cycle in Ukraine costs three to five times less than in most EU countries or the US,” the high level of specialists and technologies, the certification of many clinics according to international standards, and the fact that “Ukrainian legislation allows virtually all ART methods — donor eggs, sperm, embryos, IVF programs for married couples and single women.”
“In Ukraine, anonymous donation and the creation of embryos for storage are permitted, which is not acceptable everywhere,” he said.
Predicting the impact of the bill if it is passed, Biletsky expects that in the short term (one to two years), Ukraine may lose some of its patients for reproductive technology (ART) programs, although overall demand will remain high because IVF, donation, and embryo banking procedures will remain permitted, and Ukrainian clinics have an internationally recognized reputation and competitive prices.
However, he predicts that in the medium term (three to five years), “if the rules for foreigners remain strict (especially regarding embryo transportation, donation, and surrogacy), demand will decrease by 20-40%.”
At the same time, commenting on the impact of the bill’s proposed ban on embryo donation on the development of reproductive prospects in general, Biletsky noted that “the ban on embryo donation will result in some patients simply losing the opportunity to treat infertility, as well as an increase in the number of ‘unused’ embryos in clinics.”
“Currently, some couples voluntarily give their frozen embryos to others. If this is banned, embryos will either have to be stored (which is expensive) or destroyed. This raises the ethical question: ‘What to do with embryos that could give life?’” he said.
According to his estimates, donor embryo programs may account for up to 10-15% of all IVF procedures, so clinics specializing in “full cycles” (creation, donation, surrogacy) will lose a significant share of their clients.
“Many foreign patients came specifically for donor embryo programs — this was a unique Ukrainian advantage, because in many countries (for example, Germany and Italy) this is prohibited. The ban will mean the loss of one of the key areas of reproductive medicine. Ukraine is effectively losing one of the most humane mechanisms for helping infertile couples,“ he said.
For her part, Svitlana Shiyanova, head of assisted reproductive technologies at the Dobrobut medical network, also predicts that ”the adoption of this bill will lead to a sharp decline in international demand, as it contains two critical restrictive provisions: a ban on surrogacy services if one of the spouses is a citizen of a country where this method is prohibited, and a requirement that one of the spouses be a citizen of Ukraine (for surrogacy).”
“These provisions effectively close the international surrogacy market, which has brought significant investment to the medical sector. A sharp drop in international demand is expected,” she said.
In addition, Shiyanova noted that the ban on embryo donation provided for in the bill “is one of the most restrictive and controversial provisions of the bill,” which, also contradicts the principles of evidence-based medicine (European Society of Human Reproduction and Embryology, ESHRE) and takes away the last chance for the most vulnerable category of patients, forcing them to seek this service abroad.
“For clinics, this means excluding an important service from the list, which limits the ability to provide a full range of ART and comprehensive patient care,” she said.
According to Shiyanova, the following aspects of reproductive medicine currently require regulatory regulation: the definition of infertility, the determination of who is eligible for ART, the need to ensure the anonymity of donations, the regulation of compensation, as well as the lack of a clear mechanism for creating a single national ART registry and standardized performance monitoring.
As reported, representatives of the Ukrainian Association of Reproductive Medicine (UARM) believe that government bill No. 13683 “On the Use of Assisted Reproductive Technologies” will limit Ukrainians’ access to such technologies.
Tags: Government bill on reproductive technologies may lead to Ukraine losing its status as “Europe’s reproductive hub” – experts
The draft law “On the Use of Assisted Reproductive Technologies” (No. 13638) could radically change the provision of medical services in reproductive technologies and lead to Ukraine losing its status as the “reproductive hub of Europe,” It requires significant revision with the involvement of the professional expert community, according to experts surveyed by Interfax-Ukraine.
“According to various estimates, up to 40-60% of patients in large reproductive medicine clinics are foreigners (especially from the EU, the UK, the US, Canada, Israel, and China). If the law does not provide for transparent mechanisms for foreign patients, such as official medical visas or agreements between countries, Ukraine may lose its status as the “reproductive hub of Europe,” said Dmytro Biletsky, head of the assisted reproductive technology department at the Adonis Medical Gynecological Center (MGK) Adonis Medical Gynecological Center (MGK).
According to him, Ukraine is currently among the top 10 global destinations for reproductive technologies, thanks in particular to “affordable prices: an IVF cycle in Ukraine costs three to five times less than in most EU countries or the US,” the high level of specialists and technologies, the certification of many clinics according to international standards, and the fact that “Ukrainian legislation allows virtually all ART methods — donor eggs, sperm, embryos, IVF programs for married couples and single women.”
“In Ukraine, anonymous donation and the creation of embryos for storage are permitted, which is not acceptable everywhere,” he said.
Predicting the impact of the bill if it is passed, Biletsky expects that in the short term (one to two years), Ukraine may lose some of its patients for reproductive technology (ART) programs, although overall demand will remain high because IVF, donation, and embryo banking procedures will remain permitted, and Ukrainian clinics have an internationally recognized reputation and competitive prices.
However, he predicts that in the medium term (three to five years), “if the rules for foreigners remain strict (especially regarding embryo transport, donation, and surrogacy), demand will decrease by 20-40%.”
At the same time, commenting on the impact of the bill’s proposed ban on embryo donation on the development of reproductive prospects in general, Biletsky noted that “the ban on embryo donation will result in some patients simply losing the opportunity to treat infertility, as well as an increase in the number of ‘unused’ embryos in clinics.”
“Currently, some couples voluntarily give their frozen embryos to others. If this is banned, embryos will have to be either stored (which is expensive) or destroyed. This raises the ethical question: ‘What to do with embryos that could give life?’” he said.
According to his estimates, donor embryo programs may account for up to 10-15% of all IVF procedures, so clinics specializing in “full cycles” (creation, donation, surrogacy) will lose a significant share of their clients.
“Many foreign patients came specifically for donor embryo programs — this was a unique Ukrainian advantage, because in many countries (for example, Germany and Italy) this is prohibited. The ban will mean the loss of one of the key areas of reproductive medicine. Ukraine is effectively losing one of the most humane mechanisms for helping infertile couples,“ he said.
For her part, Svitlana Shiyanova, head of assisted reproductive technologies at the Dobrobut medical network, also predicts that ”the adoption of this bill will lead to a sharp decline in international demand, as it contains two critical restrictive provisions: a ban on surrogacy services if one of the spouses is a citizen of a country where this method is prohibited, and a requirement that one of the spouses be a citizen of Ukraine (for surrogacy).”
“These provisions effectively close the international surrogacy market, which has brought significant investment to the medical sector. A sharp drop in international demand is expected,” she said.
In addition, Shiyanova noted that the ban on embryo donation provided for in the draft law “is one of the most restrictive and controversial provisions of the draft law,” which, also contradicts the principles of evidence-based medicine (European Society of Human Reproduction and Embryology, ESHRE) and takes away the last chance for the most vulnerable category of patients, forcing them to seek this service abroad.
“For clinics, this means excluding an important service from the list, which limits the ability to provide a full range of ART and comprehensive patient care,” she said.
According to Shiyanova, the following aspects of reproductive medicine currently require regulatory regulation: the definition of infertility, the determination of who is eligible for ART, the need to ensure the anonymity of donations, the regulation of compensation, as well as the lack of a clear mechanism for creating a single national ART registry and standardized performance monitoring.
As reported, representatives of the Ukrainian Association of Reproductive Medicine (UARM) believe that government bill No. 13683 “On the Use of Assisted Reproductive Technologies” will limit Ukrainians’ access to such technologies.
ADONIS, Biletsky, BILL, reproductive, Shiyanov, TECHNOLOGIES
ADONIS Medical Group will continue developing exosome therapy based on its own biotechnology laboratory developments at its branch in Obukhov.
According to ADONIS’ press release, this area of the medical group includes its own biotechnology laboratory, cryobank, and a line of cell-free Exoprove preparations, the production of which has been established in the biotechnology laboratory at the Obukhov branch.
“Our own production allows us to guarantee the stable quality and biosafety of our products. Each batch undergoes multi-level control and has a product passport. We are developing cell-free treatment approaches for various areas of medicine, from orthopedics to gynecology,” the biotechnology laboratory notes.
Exosomes are the smallest extracellular nanoparticles that transmit regulatory signals between cells, activate physiological and reparative processes in the body, and, in particular, promote tissue regeneration and reduce systemic and local inflammation. They help cells restore their functions and maintain the body’s homeostasis. Thanks to these properties, exosome therapy is used for chronic, autoimmune, and neurological diseases, as well as in cosmetology and trichology.
The EXOPROVE line includes several cell-free preparations with clearly defined areas of application, in particular for dermatology and cosmetology, hair restoration, systemic anti-inflammatory therapy, gynecological practice and ART, and regenerative orthopedics.
All developments are based on the ADONIS medical group’s cord blood bank and other human tissues and cells, which ensures complete quality control of cell-free products at all stages — from testing donor material to the release and proper storage of the finished product.
ADONIS is a multidisciplinary medical center for adults and children, founded in 1997. Currently, the medical group of companies includes seven modern clinics in Kyiv and the region, more than 80 areas of medicine, its own laboratories, operating centers, hospitals, and departments of specialized specialists.
